1. Home
  2. PRCT vs IVA Comparison

PRCT vs IVA Comparison

Compare PRCT & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$25.87

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.00

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCT
IVA
Founded
2009
2011
Country
United States
France
Employees
N/A
77
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
PRCT
IVA
Price
$25.87
$5.00
Analyst Decision
Buy
Strong Buy
Analyst Count
11
10
Target Price
$35.44
$16.20
AVG Volume (30 Days)
1.5M
230.0K
Earning Date
04-29-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
1.71
N/A
EPS
N/A
N/A
Revenue
$308,054,000.00
N/A
Revenue This Year
$31.34
N/A
Revenue Next Year
$24.52
$751.20
P/E Ratio
N/A
N/A
Revenue Growth
37.22
N/A
52 Week Low
$19.35
$2.94
52 Week High
$64.89
$7.98

Technical Indicators

Market Signals
Indicator
PRCT
IVA
Relative Strength Index (RSI) 52.84 39.77
Support Level $22.05 $4.98
Resistance Level $26.41 $6.42
Average True Range (ATR) 1.90 0.25
MACD 0.20 0.01
Stochastic Oscillator 60.10 12.18

Price Performance

Historical Comparison
PRCT
IVA

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: